ZLJ-21457-53579 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-05
Dose 1 — Janssen/Johnson & Johnson
2021-05-06
Registered in v-safe
2021-05-06
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-05-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-05-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-05-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-05-12
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-05-19
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-06-02
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-06-09
Health check-in — day 35, single dose
Feeling: Good

Adult check-in
2021-06-18
Health check-in — day 42, single dose
Feeling: Good

Adult check-in
2021-08-04
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2021-11-03
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2022-05-07
Survey response — 12 months, dose 1
MedDRA: Ageusia, Anosmia, Pyrexia — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Loss of taste and smell. Fever.

MedDRA releases: 2024-11 · check-in free text available
2022-05-07
Report sent to call center — 12 months, dose 1
Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · 1 call case(s)
2022-05-09
Call 1 — Could Not Reach Participant
2022-05-12
Call 2 — Could Not Reach Participant

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-05	Janssen/Johnson & Johnson

Call center

Reported	Outcome	VAERS-related outcome
2022-05-07	Unsuccessful

Free text

Release 11 — 12 months, dose 1

2022-05-07

Symptoms: Loss of taste and smell. Fever.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ageusia	·	·	✓
SD	Anosmia	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release